Cannon Global Investment Management »

Tscan Therapeutics shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $139k 18k 7.94